Employee-related Liabilities, Current in USD of AGILE THERAPEUTICS INC from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Agile Therapeutics Inc quarterly Employee-related Liabilities, Current history and change rate from Q4 2020 to Q2 2024.
  • Agile Therapeutics Inc Employee-related Liabilities, Current for the quarter ending 30 Jun 2024 was $954K, a 57.4% decline year-over-year.
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

AGILE THERAPEUTICS INC Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $954K -$1.29M -57.4% 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $908K -$603K -39.9% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $832K -$1K -0.12% 31 Dec 2023 10-Q 12 Aug 2024
Q3 2023 $2.72M +$766K +39.2% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $2.24M +$697K +45.1% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $1.51M -$457K -23.2% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $833K -$1.25M -60.1% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $1.96M +$1.01M +108% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $1.55M +$148K +10.6% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $1.97M 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $2.09M +$389K +22.9% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 $942K 30 Sep 2021 10-Q/A 30 Dec 2021
Q2 2021 $1.4M 30 Jun 2021 10-Q 26 Jul 2021
Q4 2020 $1.7M 31 Dec 2020 10-K 30 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.